Andrew J Collaro1,2, Anne B Chang3,4,5,6, Julie M Marchant3,4, Mark D Chatfield5,7, Annette Dent6,8, Tamara Blake3,7, Patsi Mawn6, Kwun Fong6,7,8, Margaret S McElrea3,4,6. 1. Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Level 5a, 501 Stanley St, South Brisbane, QLD, 4101, Australia. andrew.collaro@health.qld.gov.au. 2. Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, QLD, Australia. andrew.collaro@health.qld.gov.au. 3. Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Level 5a, 501 Stanley St, South Brisbane, QLD, 4101, Australia. 4. Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, QLD, Australia. 5. Child Health Division, Menzies School of Health Research, Darwin, NT, Australia. 6. Indigenous Respiratory Outreach Care, The Prince Charles Hospital, Chermside, QLD, Australia. 7. Faculty of Medicine, The University of Queensland, St Lusia, QLD, Australia. 8. Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD, Australia.
Abstract
PURPOSE: Northern Territory (NT)-based clinical service data suggest substantial lung function impairment amongst First Nations adults as young as 18-40 years. Our objectives were to describe the burden of disease and lung function of adults living in regional-remote Queensland, identify determinants of lung function, and evaluate the impact of a specialist respiratory outreach service on lung function. METHODS: Retrospective 8-year cohort study (February 2012-March 2020) of 1113 First Nations Australian adults (and 648 non-First Nations adults) referred to respiratory outreach clinics in regional-remote Queensland. RESULTS: In the combined cohort, the forced expiratory volume in 1 s (FEV1) was clinically abnormal for 54% of First Nations patients (51% of non-First Nations patients), forced vital capacity (FVC) for 46% (36%), FEV1/FVC% for 30% (36%), and gas diffusing capacity (DLCO) for 44% (37%). A respiratory diagnosis was assigned by a respiratory physician in 78% of First Nations (76% non-First Nations) patients. Smoking, household smoke exposure, underweight BMI, and respiratory disease were associated with reduced lung function. In the 40% of patients (709/1765) followed up, FEV1 and FVC significantly improved (mean change: zFEV1 = 0.15 [95% CI 0.10-0.20]; zFVC = 0.25 [0.20, 0.31]), and FEV1/FVC% significantly reduced (mean = - 0.10 [95%CI - 0.07 to - 0.03]), with no significant change in DLCO. Patients with COPD had lower FEV1 improvement, whilst underweight and obese patients had lower FVC improvement. CONCLUSION: Regional-remote First Nations adult Queenslanders have higher lung function than previously reported, with no lung function decline observed at follow-up visit, including for those with respiratory disease.
PURPOSE: Northern Territory (NT)-based clinical service data suggest substantial lung function impairment amongst First Nations adults as young as 18-40 years. Our objectives were to describe the burden of disease and lung function of adults living in regional-remote Queensland, identify determinants of lung function, and evaluate the impact of a specialist respiratory outreach service on lung function. METHODS: Retrospective 8-year cohort study (February 2012-March 2020) of 1113 First Nations Australian adults (and 648 non-First Nations adults) referred to respiratory outreach clinics in regional-remote Queensland. RESULTS: In the combined cohort, the forced expiratory volume in 1 s (FEV1) was clinically abnormal for 54% of First Nations patients (51% of non-First Nations patients), forced vital capacity (FVC) for 46% (36%), FEV1/FVC% for 30% (36%), and gas diffusing capacity (DLCO) for 44% (37%). A respiratory diagnosis was assigned by a respiratory physician in 78% of First Nations (76% non-First Nations) patients. Smoking, household smoke exposure, underweight BMI, and respiratory disease were associated with reduced lung function. In the 40% of patients (709/1765) followed up, FEV1 and FVC significantly improved (mean change: zFEV1 = 0.15 [95% CI 0.10-0.20]; zFVC = 0.25 [0.20, 0.31]), and FEV1/FVC% significantly reduced (mean = - 0.10 [95%CI - 0.07 to - 0.03]), with no significant change in DLCO. Patients with COPD had lower FEV1 improvement, whilst underweight and obese patients had lower FVC improvement. CONCLUSION: Regional-remote First Nations adult Queenslanders have higher lung function than previously reported, with no lung function decline observed at follow-up visit, including for those with respiratory disease.
Authors: Bruce R Thompson; Sanja Stanojevic; Michael J Abramson; Richard Beasley; Andrew Coates; Annette Dent; Brenton Eckert; Alan James; Sue Filsell; A W Bill Musk; Gary Nolan; Barbara Dixon; Chris O'Dea; Jenni Savage; Janet Stocks; Maureen P Swanney; Graham L Hall Journal: Respirology Date: 2011-08 Impact factor: 6.424
Authors: Andrew J Collaro; Anne B Chang; Julie M Marchant; Ian B Masters; Leanne T Rodwell; Allan J Takken; Margaret S McElrea Journal: Lung Date: 2020-02-20 Impact factor: 2.584
Authors: Sanja Stanojevic; Brian L Graham; Brendan G Cooper; Bruce R Thompson; Kim W Carter; Richard W Francis; Graham L Hall Journal: Eur Respir J Date: 2017-09-11 Impact factor: 16.671
Authors: Andrew J Collaro; Anne B Chang; Julie M Marchant; Leanne T Rodwell; Ian B Masters; Mark D Chatfield; Margaret S McElrea Journal: Chest Date: 2020-05-06 Impact factor: 9.410
Authors: Sean R Blackall; Jae B Hong; Paul King; Conroy Wong; Lloyd Einsiedel; Marc G W Rémond; Cindy Woods; Graeme P Maguire Journal: Respirology Date: 2018-03-04 Impact factor: 6.424
Authors: Linda G Medlin; Anne B Chang; Kwun Fong; Rebecca Jackson; Penny Bishop; Annette Dent; Deb C Hill; Stephen Vincent; Kerry-Ann F O'Grady Journal: Aust Health Rev Date: 2014-09 Impact factor: 1.990
Authors: Brian L Graham; Irene Steenbruggen; Martin R Miller; Igor Z Barjaktarevic; Brendan G Cooper; Graham L Hall; Teal S Hallstrand; David A Kaminsky; Kevin McCarthy; Meredith C McCormack; Cristine E Oropez; Margaret Rosenfeld; Sanja Stanojevic; Maureen P Swanney; Bruce R Thompson Journal: Am J Respir Crit Care Med Date: 2019-10-15 Impact factor: 21.405
Authors: Subash S Heraganahally; Sanjiwika L Wasgewatta; Kelly McNamara; Carla C Eisemberg; Richard C Budd; Sumit Mehra; Dimitar Sajkov Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-09-26
Authors: Andrew J Collaro; Anne B Chang; Julie M Marchant; Mark D Chatfield; Don Vicendese; Tamara L Blake; Margaret S McElrea; Shyamali C Dharmage Journal: J Clin Med Date: 2021-12-07 Impact factor: 4.241